Related Research Articles
Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to more porous bone, and consequent increase in fracture risk.
Teriparatide, sold under the brand name Forteo, is a form of parathyroid hormone (PTH) consisting of the first (N-terminus) 34 amino acids, which is the bioactive portion of the hormone. It is an effective anabolic agent used in the treatment of some forms of osteoporosis. Teriparatide is a recombinant human parathyroid hormone analog. It has an identical sequence to the 34 N-terminal amino acids of the 84-amino acid human parathyroid hormone.
Osteopenia, known as "low bone mass" or "low bone density", is a condition in which bone mineral density is low. Because their bones are weaker, people with osteopenia may have a higher risk of fractures, and some people may go on to develop osteoporosis. In 2010, 43 million older adults in the US had osteopenia. Unlike osteoporosis, osteopenia does not usually cause symptoms, and losing bone density in itself does not cause pain.
Renal osteodystrophy is currently defined as an alteration of bone morphology in patients with chronic kidney disease (CKD). It is one measure of the skeletal component of the systemic disorder of chronic kidney disease-mineral and bone disorder (CKD-MBD). The term "renal osteodystrophy" was coined in 1943, 60 years after an association was identified between bone disease and kidney failure.
Osteocalcin, also known as bone gamma-carboxyglutamic acid-containing protein (BGLAP), is a small (49-amino-acid) noncollagenous protein hormone found in bone and dentin, first identified as a calcium-binding protein.
The International Bone and Mineral Society (IBMS), formerly International Conferences on Calcium Regulating Hormones, is or was a learned society in the field of bone and mineral metabolism. There is no indication of activities or publications by the society since 2017.
Fuller Albright was an American endocrinologist who made numerous contributions to his field, especially to the area of calcium metabolism. Albright made great strides and contributions to the understanding of disorders associated with calcium and phosphate abnormalities in the body. He also was a published author and in his books he detailed his findings.
The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established in 1977 to promote excellence in bone and mineral research and to facilitate the translation of that research into clinical practice. The ASBMR has a membership of nearly 4,000 physicians, basic research scientists, and clinical investigators from around the world.
Masayoshi Yamaguchi is a biomedical scientist and researcher, most known for his contributions to biomedical fields including biochemistry, endocrinology, metabolism, nutrition, pharmacology, and toxicology. He is a full professor in the Cancer Biology Program at the University of Hawaii Cancer Center, University of Hawaii at Manoa (UH), focusing on research in bone and calcium endocrinology, metabolism, cell calcium signaling, gene regulation, dietary prevention of osteoporosis, carcinogenesis, and cancer therapy.
Bone health refers to the overall condition and strength of the human skeletal system, which is crucial for maintaining mobility, preventing fractures, and supporting overall well-being throughout life. It is influenced by various factors, including genetics, nutrition, physical activity, and hormonal balance. Optimal bone health is characterized by adequate bone mineral density (BMD) and proper bone microarchitecture, which together contribute to bone strength. Osteoporosis, a skeletal disorder characterized by compromised bone strength and increased risk of fractures, is a major concern in bone health, particularly among older adults. Maintaining good bone health involves a combination of adequate calcium and vitamin D intake, regular weight-bearing exercise, and avoiding risk factors such as smoking and excessive alcohol consumption. Recent research has also highlighted the potential role of the gut microbiome in bone health, suggesting a complex interplay between various physiological systems in maintaining skeletal integrity.
The Australian and New Zealand Bone and Mineral Society (ANZBMS) is a not-for-profit collegiate organisation and principal professional body for scientists and clinicians involved in bone and mineral metabolism research in Australia and New Zealand.
Ambrish Mithal is an Indian endocrinologist and diabetologist. He secured MBBS from GSVM Medical College, master's degree (DM) from the All India Institute of Medical Sciences, New Delhi. Then he worked at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow and, later, at Apollo Hospitals, New Delhi before joining Medanta the Medicity as Chairman, Division of Endocrinology and Diabetes where he worked from 2009 to 2019. Subsequently, he joined Max Health Care where he is the chairman and head of Endocrinology and Diabetes department.
Nikhil Tandon is an Indian endocrinologist, medical academic and the head of the department of endocrinology, metabolism and diabetes at the All India Institute of Medical Sciences. He is a recipient of Dr. B. C. Roy Award, the highest Indian medical award in 2005 and was honoured by the Government of India in 2015 with Padma Shri, the fourth highest Indian civilian award.
David Goltzman is a Canadian endocrinologist, Professor of Medicine and Physiology, and A.G. Massabki Chair in Medicine at McGill University in Montreal, Quebec. He has been the Director of the Centre for Bone and Periodontal Research and also holds the position of Senior Scientist at the McGill University Health Centre Research Institute in the Metabolic Disorders and Complications Program.
Rebecca D. Jackson was a medical researcher, medical practitioner and professor of endocrinology, diabetes and metabolism. Her research was significant in the understanding and treatment of osteoporosis. She also researches the opioid crisis in Ohio.
Iain Macintyre FRS was a British endocrinologist who made important contributions to the understanding of calcium regulation and bone metabolism. Shortly after the hormone calcitonin had been described by Harold Copp, Macintyre's team was the first to isolate and sequence the hormone and to demonstrate its origin in the parafollicular cells of the thyroid gland. He subsequently analysed its physiological actions. Along with H. R. Morris he isolated and sequenced calcitonin gene-related peptide. Later research centred on the role played by nitric oxide on bone metabolism.
Abida Sophie Jamal is a Canadian endocrinologist and former osteoporosis researcher who was at the centre of a scientific misconduct case in the mid-to-late 2010s. Jamal published a high-profile paper suggesting that the heart medication nitroglycerin was a treatment for osteoporosis, and was later demonstrated to have misrepresented her results. She received a lifetime ban from receiving funding from the Canadian Institutes of Health Research and was named directly in their disclosure report, becoming the first person mentioned by name by the institute for scientific misconduct. Jamal was later stripped of her medical license for two years, regaining it in a controversial 3–2 decision.
Endocrine & Metabolism Research Institute (EMRI) is one of Tehran University of Medical Sciences research institute with a mission to combine clinical care, research, and education in diabetes, endocrine and metabolic diseases.
Ghada El-Hajj Fuleihan is a professor of medicine, researcher and physician scientist at the American University of Beirut. Prior to that she held the position of founding Director of the Calcium Metabolism Program at Brigham and Women's Hospital. She is also the Bernard Lown Scholar in the Department of Global Health and Population at the Harvard T. H. Chan School of Public Health. In 2022, she became a member of the editorial board of Mayo Clinic Proceedings.
Pisit Pitukcheewanont, also known as "Dr. Duke" is a Doctor of Medicine, a former professor of Clinical Pediatrics and, a philanthropist. Currently, he is a Adjunct Professor of Clinical Pediatrics at Keck School of Medicine of the University of Southern California, the President of a nonprofit organization, The Human Growth Foundation and Senior Vice President, Global Clinical Development and Medical Affairs at a large pharmaceutical.
References
- ↑ Academic Unit of Bone Metabolism
- ↑ Eastell, Richard (1984). Investigation of metabolic bone disease by in vivo neutron activation analysis (Thesis). hdl:1842/18160.
- ↑ "Eastell, Richard, Professor". www.sheffield.ac.uk. 25 May 2022. Retrieved 4 December 2022.
- ↑ Eastell, Richard; Riggs, B. Lawrence; Vieira, Nancy E.; Yergey, Alfred L. (3 December 2009). "One-day test using stable isotopes to measure true fractional calcium absorption". Journal of Bone and Mineral Research. 4 (4): 463–468. doi:10.1002/jbmr.5650040403. PMID 2816495. S2CID 34666862.
- ↑ "Professor Richard Eastell | Medical School | The University of Sheffield". www.sheffield.ac.uk. 3 February 2021. Retrieved 16 March 2021.
- ↑ Phil Baty, "Academic made ‘untrue’ declaration about ‘full access’ to research material, GMC finds", Times Higher Education, 10 November 2009
- ↑ Phil Baty, "Bone professor faces GMC probe", Times Higher Education, 22 September 2009
- ↑ "Professor Richard Eastell awarded the Linda Edwards Award by the National Osteoporosis Society", 4 December 2018
- ↑ European Society of Endocrinology
- ↑ Bone Research Society
- ↑ American Society for Bone and Mineral Research
